Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04147910 · ClinicalTrials.gov registry record · Phase 1
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356
A Phase 1 study of Healthy Male Subjects, sponsored by Kyowa Kirin.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04147910: Completed Phase 1 study of Healthy Male Subjects, sponsored by Kyowa Kirin.
NCT04147910 is a Phase 1 study of Healthy Male Subjects that has completed, run by Kyowa Kirin. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04147910, a Phase 1 study of Healthy Male Subjects, has completed, sponsored by Kyowa Kirin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, single-dose study in healthy male subjects to investigate the absorption, metabolism, and excretion (AME) of KW-6356.
Primary Outcome
Maximum observed concentration (KW-6356 in plasma and total radioactivity in plasma and blood).
Conditions Studied
Interventions
- DRUG KW-6356
Study Locations (1)
Wisconsin
- Covance Clinical Research Unit Inc. - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-08-21 |
| Est. Completion | 2019-10-02 |
| Phase | Phase 1 |
What the finished NCT04147910 record still lists
NCT04147910 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Healthy Male Subjects appearing as the primary indexed condition, and to 1 intervention - of which KW-6356 is the first listed.
NCT04147910 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04147910 about?
NCT04147910 is a clinical study titled "Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356". This is an open-label, single-dose study in healthy male subjects to investigate the absorption, metabolism, and excretion (AME) of KW-6356.
What is the current status of trial NCT04147910?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2019-08-21. Estimated completion is 2019-10-02.
What conditions does trial NCT04147910 study?
This clinical trial studies the following conditions: Healthy Male Subjects.
What interventions are being tested in trial NCT04147910?
The interventions under investigation include: KW-6356 (DRUG).
Who is sponsoring clinical trial NCT04147910?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04147910 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04147910's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI